Literature DB >> 34312528

CAR T cells show promise in mesothelioma.

David Killock1.   

Abstract

Entities:  

Year:  2021        PMID: 34312528     DOI: 10.1038/s41571-021-00547-4

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab.

Authors:  Prasad S Adusumilli; Marjorie G Zauderer; Isabelle Rivière; Stephen B Solomon; Valerie W Rusch; Roisin E O'Cearbhaill; Amy Zhu; Waseem Cheema; Navin K Chintala; Elizabeth Halton; John Pineda; Rocio Perez-Johnston; Kay See Tan; Bobby Daly; Jose A Araujo Filho; Daniel Ngai; Erin McGee; Alain Vincent; Claudia Diamonte; Jennifer L Sauter; Shanu Modi; Devanjan Sikder; Brigitte Senechal; Xiuyan Wang; William D Travis; Mithat Gönen; Charles M Rudin; Renier J Brentjens; David R Jones; Michel Sadelain
Journal:  Cancer Discov       Date:  2021-07-15       Impact factor: 39.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.